Simulations Plus(SLP) - 2025 Q3 - Quarterly Results

Exhibit 99.1 Simulations Plus Reports Third Quarter Fiscal 2025 Financial Results Updated full-year revenue guidance of between $76 to $80 million and adjusted diluted EPS of $0.93 to $1.06 RESEARCH TRIANGLE PARK, NC, July 14, 2025 – Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today reported financial results fo ...